|drug2826||Pathogen-specific aAPC Wiki||1.00|
|drug1980||Internet-based self-help Wiki||1.00|
There is one clinical trial.
As part of the ROCO project, the University of Bern is investigating an online self-help program for people who are psychologically distressed due to the situation surrounding Covid-19. The ROCO program offers support in overcoming this psychological distress. ROCO stands for a 3-week online self-help program comprising 6 modules. The aim of the study is to investigate the efficacy of an online self-help intervention for people with psychological distress due to the situation surrounding Covid-19. All participants will be randomized to one of two groups: The first group receives direct access to the online self-help intervention and the second group is a waiting control group that receives access to the program 3 weeks later. In both conditions additional care or treatment is allowed. There are 4 assessments, which all take place online: baseline, post assessment (after 3 weeks) and two follow-up assessments (after 6 and 18 weeks). All participants from both groups are asked to fill out all assessments.
Description: 9-item questionnaire assessing depressive symptomsMeasure: Patient Health Questionnaire (Löwe et al., 2002) Time: up to 18 weeks
Description: 4-item questionnaire assessing suicidal ideationMeasure: Suicide Behavior Questionnaire Revised (Glaesmer et al., 2018) Time: up to 18 weeks
Description: 21-item questionnaire assessing depression, anxiety and stress symptomsMeasure: DASS-21: Depression, Angst, Stress-Skala (Lovibond & Lovibond, 1995) Time: up to 18 weeks
Description: 12-item questionnaire assessing various aspects of well-beingMeasure: SF-12: Short Form Health Survey (Ware et al., 1996) Time: up to 18 weeks
Description: 10-item questionnaire assessing optimism and pessimismMeasure: LOT-R: Revised Life Orientation Test (Herzberg et al., 2006) Time: up to 18 weeks
Description: 6-item questionnaire assessing embittermentMeasure: Berner Verbitterungsinventar Kurzversion (Znoj, 2008) Time: up to 18 weeks
Description: 27-item questionnaire assessing emotion regulation skillsMeasure: Emotion regulation skills SEK-27 (Berking & Znoj, 2008) Time: up to 18 weeks
Description: 10-item questionnaire assessing general self-efficacyMeasure: SWE: Skala zur Allgemeinen Selbstwirksamkeit (Jerusalem & Schwarzer, 2003) Time: up to 18 weeks
Description: 9-item questionnaire assessing lonelinessMeasure: UCLA Loneliness Scale (Döring & Bortz, 1993) Time: up to 18 weeks
Description: 10-item questionnaire assessing resilienceMeasure: Connor-Davidson Resilience Scale (Sarubin et al., 2015) Time: up to 18 weeks
Description: 8-item questionnaire assessing content with an online-programMeasure: ZUF-8: Zufriedenheitsfragebogen (Attkisson & Zwick, 1982) Time: at 3 weeks for experimental group and at 6 weeks for waiting control group
Description: 10-item questionnaire assessing usability of an online-programMeasure: SUS: System Usability Scale (Brooke, 1996) Time: at 3 weeks for experimental group and at 6 weeks for waiting control group
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports